Alvotech Warrant

Yahoo Finance • 2 months ago

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

Alvotech REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will r... Full story

Yahoo Finance • 3 months ago

Exploring 3 High Growth Tech Stocks in the US Market

The United States market has shown positive momentum, climbing 2.7% in the last week and up 13% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this favorable environment, identifying high grow... Full story

Yahoo Finance • 5 months ago

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Alvotech The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved... Full story